OTCMKTS:HSDTHelius Medical Technologies Stock Price, Forecast & News

$0.27

0.00 (0.00 %)

(As of 04/7/2020 03:28 PM ET)

Add

Compare

Today's Range

$0.27

Now: $0.27▼

$0.30

50-Day Range

$0.28

MA: $0.60▼

$0.93

52-Week Range

$0.26

Now: $0.27▼

$6.58

Volume184,963 shs

Average Volume319,021 shs

Market Capitalization$6.94 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Helius Medical Technologies, Inc. is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain's ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device. The device, when used in combination with physiotherapy, is designed to enhance the brain's ability to compensate for damage due to trauma or disease. The Company's PoNS device is designed to induce cranial nerve non-invasive neuromodulation through an increase in stimulation of the facial and trigeminal nerves, which innervate the tongue. The PoNS device is developed to deliver to the tongue a non-invasive neurostimulation, in a form that induces neuromodulation. The PoNS device is an electrical pulse generator that delivers controlled electrical stimulation to the tongue.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Helius Medical Technologies.

2.3 Community Rank

Outperform Votes
Helius Medical Technologies has received 121 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Helius Medical Technologies has received 147 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Helius Medical Technologies has received 54.85% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Helius Medical Technologies and other stocks. Vote “Outperform” if you believe HSDT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HSDT will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Helius Medical Technologies does not currently pay a dividend.
Dividend Growth
Helius Medical Technologies does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Helius Medical Technologies insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 23.00% of the stock of Helius Medical Technologies is held by insiders.

0.0 Earnings and Valuation

Overall Beat the Market Rank^™

0.46 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Electromedical equipment

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:HSDT

Previous Symbol

CUSIPN/A

CIK1610853

Webhttp://www.heliusmedical.com/

Phone215-944-6100

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

EmployeesN/A

Outstanding Shares25,903,000

Market Cap$6.94 million

Next Earnings DateN/A

OptionableNot Optionable

Receive HSDT News and Ratings via Email

Sign-up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.

Helius Medical Technologies (OTCMKTS:HSDT) Frequently Asked Questions

How has Helius Medical Technologies' stock been impacted by COVID-19 (Coronavirus)?

Helius Medical Technologies' stock was trading at $0.5401 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HSDT stock has decreased by 50.4% and is now trading at $0.2681. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Helius Medical Technologies?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Helius Medical Technologies in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Helius Medical Technologies.

How were Helius Medical Technologies' earnings last quarter?

Helius Medical Technologies Inc (OTCMKTS:HSDT) posted its quarterly earnings data on Thursday, March, 12th. The company reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.21) by $0.02. The business earned $0.15 million during the quarter, compared to analysts' expectations of $0.10 million. View Helius Medical Technologies' earnings history.

What guidance has Helius Medical Technologies issued on next quarter's earnings?

Helius Medical Technologies updated its FY 2020 After-Hours earnings guidance on Thursday, March, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2-2 million.

Has Helius Medical Technologies been receiving favorable news coverage?

News stories about HSDT stock have been trending very negative recently, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Helius Medical Technologies earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutHelius Medical Technologies.

Who are some of Helius Medical Technologies' key competitors?

Some companies that are related to Helius Medical Technologies include Precision Optics (PEYE), IRIDEX (IRIX), Second Sight Medical Products (EYES), CHF Solutions (CHFS), ENDRA Life Sciences (NDRA), Viveve Medical (VIVE), Digirad (DRAD), Vaso (VASO), Non-Invasive Monitoring Systems (NIMU), ReShape Lifesciences (RSLSD), Reshape Lifesciences (RSLS), Nexeon Medsystems (NXNN), Trimedyne (TMED), Guided Therapeutics (GTHP) and Magna-Lab (MAGAA).

What other stocks do shareholders of Helius Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Helius Medical Technologies investors own include Mazor Robotics (MZOR), Energy Transfer LP Unit (ET), Coty (COTY), Actinium Pharmaceuticals (ATNM), G&K Services (GK), Martin Midstream Partners (MMLP), Opko Health (OPK), Carnival (CCL), Franco Nevada (FNV) and Myovant Sciences (MYOV).

Who are Helius Medical Technologies' key executives?

Helius Medical Technologies' management team includes the following people:

Philippe Deschamps, President, Chief Executive Officer, Director
Joyce N. LaViscount, Chief Financial Officer, Chief Operating Officer
Brian Bapty, Vice President, Strategy and Business Development
Jonathan Sackier, Chief Medical Officer
Dane Andreeff, Director
Huaizheng Peng, Director
Mitch Eugene Tyler, Director
Thomas E. Griffin, Independent Director
Edward M. Straw, Independent Director

What is Helius Medical Technologies' stock symbol?

Helius Medical Technologies trades on the OTCMKTS under the ticker symbol "HSDT."

How do I buy shares of Helius Medical Technologies?

Shares of HSDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Helius Medical Technologies' stock price today?

One share of HSDT stock can currently be purchased for approximately $0.27.

How big of a company is Helius Medical Technologies?

Helius Medical Technologies has a market capitalization of $6.94 million. View additional information about Helius Medical Technologies.

What is Helius Medical Technologies' official website?

The official website for Helius Medical Technologies is http://www.heliusmedical.com/.

How can I contact Helius Medical Technologies?

Helius Medical Technologies' mailing address is 642 NEWTOWN YARDLEY ROAD SUITE 100, NEWTOWN PA, 18940. The company can be reached via phone at 215-944-6100 or via email at [email protected]

This page was last updated on 4/7/2020 by MarketBeat.com Staff